Aurinia Pharmaceuticals Inc. (AUPH): Depreciation & Amortization
$19.45M
Year ended 2025-12-31
$19.38M
Trailing 12 months to 2026-06-30
+93.0%
3-year compound annual growth
+70.0%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $19.45M | 0.0% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $19.45M | +67.0% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $11.65M | +330.4% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $2.71M | -2.0% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $2.76M | +101.4% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $1.37M | n/a | 2023-02-28, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | 2025-12-31 | $19.45M | 0.0% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $1.55M | -8.3% |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $27.71M | -9.9% |
| Vera Therapeutics, Inc. (VERA) | 2025-12-31 | $468.0K | +345.7% |
| NewAmsterdam Pharma Co N.V. (NAMS) | 2025-12-31 | $220.0K | +94.7% |
| Spyre Therapeutics, Inc. (SYRE) | 2025-12-31 | $0 | n/a |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | $6.02M | -2.2% |
| Arvinas, Inc. (ARVN) | 2025-12-31 | $3.00M | -34.8% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $6.42M | -10.5% |
Compare AUPH, KNSA, CYRX, VERA side by side · Screen every company in Pharmaceutical Preparations ↗